A mesoporous iron single-atom nanozyme with cascade ROS scavenging and antibiotic/antimicrobial peptide co-delivery capabilities for bacterial infected wound healing
Abstract
Bacterial infected inflammation is a major cause of delayed wound healing, and single antibacterial or anti-inflammatory strategies are often insufficient to address the complex infectious microenvironment. To overcome this limitation, we employed a dual-template strategy to construct a hollow-structured Fe single-atom nanozyme (Fe-mNC) with a hierarchical micro/mesoporous structure and further developed a nanozyme-based drug delivery system (FNMA) to achieve synergistic antibacterial and anti-inflammatory therapy. The introduction of mesoporous architecture significantly increased the specific surface area and mass-transfer efficiency while maintaining highly dispersed Fe-N4 single-atom active sites, endowing Fe-mNC with excellent superoxide dismutase- and catalase-like cascade catalytic activities for efficient reactive oxygen species (ROS) scavenging. Benefiting from its structural advantages, Fe-mNC enabled efficient loading and release of the antibiotic moxifloxacin (MOX) and antimicrobial peptides (AMPs), resulting in synergistic antibacterial effects. In vitro studies demonstrated that the disruption of bacterial membranes by AMPs significantly enhanced the accessibility of MOX, leading to improved bactericidal efficacy, while Fe-mNC effectively eliminated excess ROS and alleviated cellular oxidative stress. Furthermore, a S.aureus-infected mouse skin wound model confirmed that FNMA significantly eliminated bacteria at the infection site, suppressed inflammatory…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.